Upstream获得2亿美元战略投资

March 10, 2022 0 Comments

Upstream是一家美国免疫药物研发商,专注于药物研发领域,主要从事药物研发业务,致力于治疗炎症性疾病药物开发。近日宣布获得2亿美元战略投资,奥博资本OrbiMed投资。

Leave a Reply

Your email address will not be published. Required fields are marked *